Bothell, Washington
February 26, 2007
Eden Bioscience Corporation (NasdaqCM:EDEN - News) today
announced that it has received all shareholder approvals
required to proceed with its previously announced sale of the
Company's harpin protein technology and substantially all of the
assets related to its agricultural and horticultural markets to
Plant Health Care, Inc., a subsidiary of
Plant Health Care, plc
(AIM: PHC).
The Company will retain the
exclusive worldwide right to sell its harpin protein-based plant
health products in the home and garden market. The proposed sale
was approved by over two-thirds of the approximately 8.1 million
shares entitled to vote on the proposal.
As a result, the Company expects
to close the sale on or about February 27, 2007
Eden Bioscience is a plant technology company focused on
developing, manufacturing and marketing innovative, natural
protein-based products for agriculture. The Company believes
that its technology and products provide growers with new tools
to improve crop production and plant protection. The Company's
products are based on naturally occurring proteins called
"harpins," which activate a plant's intrinsic ability to protect
itself through growth and stress-defense responses. These
responses enhance overall plant health, improve plant vigor and
stamina, and result in improved crop quality, yield, and/or
shelf life.
Other news about
Plant
Health Care, plc |
|
